FARMAK INTERNATIONAL SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ

TAX ID7010505403

KRS0000589765

Share capital43,583,000.00 zł

★ ★ ★ ★ ★ ★ ★ ★ ★ ★

No opinion. Add your first review

address

UL. ALEJA JANA PAWŁA II 22, 00-133 WARSZAWA

Show on map

Is this your company?Update company information to get new customers, get notified of new reviews, and more!

Register Data

Full name

FARMAK INTERNATIONAL SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ

uses securityreCAPTCHA

Privacy – Terms of Use

Legal address

UL. ALEJA JANA PAWŁA II 22, 00-133 WARSZAWA

Show on map

NIP

7010505403

REGON

362449685

KRS

0000589765

Legal form

limited liability company

Register Address

UL. ALEJA JANA PAWŁA II 22, 00-133 WARSZAWA

Date of registration in KRS

2015-12-07

Date of commencement of economic activity

2015-12-07

Act signature

WA.XII NS-REJ.KRS/15070/25/626

Pkd codes

10.86.Z - Production of homogenized food products and diet food

46.19.Z - Activity of agents involved in wholesale trade of non-specialized goods

46.38.Z - Wholesale trade of other food products

46.46.Z - Wholesale trade of pharmaceutical and medical products

46.75.Z - Wholesale trade

46.90.Z - Non-specialized wholesale trade

49.41.Z - Road freight transport

52.10.B - Warehousing and storage of other goods

73.20.Z - Market research and public opinion polling

Payer VAT status

Unregirestered

Company authorities

representation authorityMANAGEMENT

representation type

DO REPREZENTOWANIA SPÓŁKI, SKŁADANIA OŚWIADCZEŃ I PODPISYWANIA W IMIENIU SPÓŁKI UPRAWNIONY JEST KAŻDY CZŁONEK ZARZĄDU SAMODZIELNIE

MANAGEMENT

Pavlo Savenko

Chairman Of The Board, 36 years old

shareholders

FARMAK GROUP LIMITED

100% 43583 udziały o łącznej wartości 43.583.000,00 zł

Financial data

Net sales [PLN]

Gross profit / loss [PLN]

Automatically generated based on financial statements from KRS Registry

	2021	2022	2023
	M PLN	M PLN	M PLN	%
Gross profit (loss)	-0,7	-0,4	-0,5	-20,3
EBITDA	-0,4	-0,1	-0,1	36
Short time liabilities	0,7	2	2,8	35,2
Equity capital	48,6	57,2	56,8	-0,8
Operating profit (EBIT)	-0,7	-0,5	-0,5	0,7
Assets	49,3	59,3	59,6	0,5
Net profit (loss)	-0,8	-0,4	-0,4	-22,6
Cash	0	0,4	0,2	-54
Net income from sale	0,3	0,7	0,8	15
Liabilities and provisions for liabilities	0,8	2,1	2,8	34
Working assets	9,7	2	0,9	-53,7
Depreciation	0,3	0,4	0,4	7,2
	%	%	%	p.p.
Profitability of capital	-1,7	-0,6	-0,8	-0,2
Equity capital to total assets	98,4	96,5	95,3	-1,2
Gross profit margin	-244,2	-51,5	-53,9	-2,4
EBITDA Margin	-120,1	-12,4	-6,9	5,5
	Days	Days	Days	Days
Short term commitment turnover cycle	820	1009	1186	177

Current financial liquidity indicator	14.157963752746582	0.9884564876556396	0.3381045162677765	-0,7
Net dept to EBITDA	-0.4499482810497284	-11.126729011535645	-40.18407440185547	-29,1